UCB Pharma Limited

208 Bath Road, Slough, Berkshire, SL1 3WE
Telephone: +44 (0)1753 534 655
Medical Information Direct Line: +44 (0)1753 447 690
Medical Information e-mail: Medicalinformationuk@ucb.com
Customer Care direct line: +44 (0) 1773 510123

Patient Information Leaflet last updated on the eMC: 17/10/2011
PIL Parvolex 200 mg/ml Concentrate for Solution for Infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 17/10/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
Updated on 10/02/2011 and displayed until 17/10/2011
Reasons for adding or updating:
  • Change to how the medicine works
Updated on 26/01/2011 and displayed until 10/02/2011
Reasons for adding or updating:
  • Change of trade or generic name
Updated on 24/03/2010 and displayed until 26/01/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 02/03/2010 and displayed until 24/03/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change due to user-testing of patient information
Updated on 10/07/2008 and displayed until 02/03/2010
Reasons for adding or updating:
  • Change to name of manufacturer
Updated on 13/09/2002 and displayed until 10/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   acetylcysteine